SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with a favourable outcome.

ABSTRACT:

Background and purpose

The spectrum of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2), includes different neurologic manifestations of the central and peripheral nervous system.

Methods

From March through April 2020, in two university hospitals located in western Switzerland, we examined three patients with Guillain-Barré syndrome (GBS) following SARS-CoV-2.

Results

These cases were characterized by a primary demyelinating electrophysiological pattern (Acute inflammatory demyelinating polyneuropathy or AIDP) and a less severe disease course compared to recently published case series. Clinical improvement was observed in all patients at week five. One patient was discharged from hospital after full recovery with persistence o

SUBMITTER: Lascano AM 

PROVIDER: S-EPMC7300656 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature